webIMarS – Australia

February 12, 2025 - Virtual

The International Myeloma Society (IMS) is proud to announce webIMarS, a new webinar series co-hosted in partnership with local hematology societies. These 90-minute webinars on Relapsed Refractory Multiple Myeloma will be led by local faculty and are designed for regional audiences. The goal of this series is to share updated knowledge in diagnosis, monitoring, and treatment of Plasma Cell malignancies with a focus on the local practice patterns.

On February 12, 2025 the IMS and Myeloma Australia will co-host a 90-minute complimentary webinar for healthcare professionals who actively treat patients with multiple myeloma in Australia.

Program

Special thanks to our co-host

About webIMarS

These 90-minute webinars on Relapsed Refractory Multiple Myeloma will be led by local faculty and designed for a regional audience. The goal of this series is to share updated knowledge in diagnosis, monitoring, and treatment of Plasma Cell malignancies with a focus on the local practice patterns.

Register Now

Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.

The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

Login
See All of the Member Benefits
Become a Member Today

Stay updated on our Events